Strata Critical Medical (SRTA) Operating Leases (2020 - 2026)

Strata Critical Medical has disclosed Operating Leases across 7 years of filings, most recently posting $3.5 million for Q1 2026.

• In Q1 2026, Operating Leases fell 38.99% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (down 38.99% YoY), while the FY2025 annual figure was $2.7 million, up 13.66% from the prior year.
• Operating Leases improved to $3.5 million in Q1 2026, from $2.7 million in the prior quarter.
• Over the last five years, Operating Leases for SRTA reached as high as $23.7 million in Q3 2024 and fell as low as $962000.0 in Q1 2022.
• The 5-year median for Operating Leases is $14.5 million (2022), against an average of $11.7 million.
• Annual changes were most pronounced in 2022 — Operating Leases surged 5284.89% — and 2024, when it plunged 88.16%.
• A 5-year view of Operating Leases shows it stood at $15.0 million in 2022, then soared by 31.85% to $19.7 million in 2023, then sank by 88.16% to $2.3 million in 2024, then climbed by 13.66% to $2.7 million in 2025, then soared by 31.11% to $3.5 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $3.5 million, $2.7 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.